Differential hydrolysis of homocysteine thiolactone by purified human serum 192Q and 192R PON1 isoenzymes

被引:20
作者
Bayrak, Ahmet [1 ]
Bayrak, Tulin [1 ]
Demirpence, Ediz [1 ]
Kilinc, Kamer [1 ]
机构
[1] Hacettepe Univ, Fac Med, Dept Biochem, TR-06100 Ankara, Turkey
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2011年 / 879卷 / 01期
关键词
Paraoxonase; 1; Purification; Polymorphism; Atherosclerosis; Homocysteine thiolactone; PLATELET-ACTIVATING-FACTOR; PARAOXONASE PON1; FACTOR ACETYLHYDROLASE; ACTIVE-SITE; POLYMORPHISM; PURIFICATION; PROTEIN; RISK; HYDROLASE; IDENTIFICATION;
D O I
10.1016/j.jchromb.2010.11.006
中图分类号
Q5 [生物化学];
学科分类号
070307 [化学生物学];
摘要
Human serum paraoxonase 1 (PON1) is a HDL-associated enzyme that catalyzes the hydrolysis of a variety of aromatic carboxylic acid esters and several organophosphates. Recently it has been suggested that a physiological substrate of serum PON1 is homocysteine thiolactone which is a putative risk factor in atherosclerosis. In this study, human (192)Q and R-192 PON1 isoenzymes were purified from the respective phenotype human serum, using a protocol consisting of ammonium sulfate precipitation and four chromatography steps: gel filtration, ion-exchange, non-specific affinity, and a second ion-exchange. Using paraoxon as substrate, overall purification fold was found as 742 for R-192 PON1 and 590 for (192)Q PON1. The final purified enzymes were shown as single protein bands close to 45 kDa on SDS-PAGE and confirmed by Western blot. Substrate kinetics were studied with phenyl acetate, paraoxon and homocysteine thiolactone. Both PON1 isoenzymes showed mixed type inhibition with phenyl acetate. K-m values of (192)Q and R-192 PON1 for homocysteine thiolactone were 23.5 mM and 22.6 mM respectively. For R-192 PON1, the V-max was 2.5-fold and k(cat)/K-m was 2.6-fold higher than those for (192)Q PON1 when homocysteine thiolactone is used as substrate. The present data suggest that defining (192)Q and R-192 PON1 isoforms could be a good predictor and prognostic marker in the cardiovascular risk assessment. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:49 / 55
页数:7
相关论文
共 51 条
[1]
Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization [J].
Aharoni, A ;
Gaidukov, L ;
Yagur, S ;
Toker, L ;
Silman, I ;
Tawfik, DS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (02) :482-487
[2]
Apolipoprotein A-I promotes the formation of phosphatidylcholine core aldehydes that are hydrolyzed by paraoxonase (PON-1) during high density lipoprotein oxidation with a peroxynitrite donor [J].
Ahmed, Z ;
Ravandi, A ;
Maguire, GF ;
Emili, A ;
Draganov, D ;
La Du, BN ;
Kuksis, A ;
Connelly, PW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (27) :24473-24481
[3]
Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities - Selective action of human paraoxonase allozymes Q and R [J].
Aviram, M ;
Billecke, S ;
Sorenson, R ;
Bisgaier, C ;
Newton, R ;
Rosenblat, M ;
Erogul, J ;
Hsu, C ;
Dunlop, C ;
La Du, B .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (10) :1617-1624
[4]
Beltowski J, 2004, J CARDIOVASC PHARM, V43, P121
[5]
Selective plasma hydrolysis of glucocorticoid γ-lactones and cyclic carbonates by the enzyme paraoxonase:: An ideal plasma inactivation mechanism [J].
Biggadike, K ;
Angell, RM ;
Burgess, CM ;
Farrell, RM ;
Hancock, AP ;
Harker, AJ ;
Irving, WR ;
Ioannou, C ;
Procopiou, PA ;
Shaw, RE ;
Solanke, YE ;
Singh, OMP ;
Snowden, MA ;
Stubbs, RJ ;
Walton, S ;
Weston, HE .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (01) :19-21
[6]
Billeclke S, 2000, DRUG METAB DISPOS, V28, P1335
[7]
IDENTIFICATION OF A DISTINCT HUMAN HIGH-DENSITY-LIPOPROTEIN SUBSPECIES DEFINED BY A LIPOPROTEIN-ASSOCIATED PROTEIN, K-45 - IDENTITY OF K-45 WITH PARAOXONASE [J].
BLATTER, MC ;
JAMES, RW ;
MESSMER, S ;
BARJA, F ;
POMETTA, D .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 211 (03) :871-879
[8]
Polymorphisms of paraoxonase (PON1) and their significance in clinical toxicology of organophosphates [J].
Costa, LG ;
Cole, TB ;
Furlong, CE .
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 2003, 41 (01) :37-45
[9]
The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin [J].
Davies, HG ;
Richter, RJ ;
Keifer, M ;
Broomfield, CA ;
Sowalla, J ;
Furlong, CE .
NATURE GENETICS, 1996, 14 (03) :334-336
[10]
Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischernic stroke [J].
Demirdogen, Birsen Can ;
Turkanoglu, Aysun ;
Bek, Semai ;
Sanisoglu, Yavuz ;
Demirkaya, Seref ;
Vural, Okay ;
Arinc, Emel ;
Adali, Orhan .
CLINICAL BIOCHEMISTRY, 2008, 41 (1-2) :1-9